Healthcare and Life Sciences investment is a key area of focus for the ISIF, offering significant risk adjusted returns and local economic impact. Life sciences has become one of Ireland’s most successful industries and in the context of Brexit and the economic shock of COVID-19, the ISIF seeks to support this sector as a key enabler of economic resilience and recovery. Notably, there is opportunity to leverage the local skill base, strong research activity and the growth of cross-disciplinary fields in ICT, genomics and digital innovation, to diversify beyond manufacturing and gain a foothold in new fields such as Cell & Gene Therapy and Connected Health.
Technology innovation at the level of venture-backed enterprises is critical to maintaining Ireland’s reputation as a destination of choice for Life Science activity. The ISIF is an important contributor to this ecosystem through its LP activity, its partnerships with strategic platforms, and its capacity to take direct interests alongside partners. ISIF prioritises venture firms with track records of leading rounds and attracting syndicates of high calibre international investors and builds deep strategic partnerships with these. The ISIF supports a diverse portfolio of venture funds, with the capacity and expertise to invest smart capital into Irish businesses, supporting early-stage technology and company creation to later-stage clinical and commercial assets. ISIF backed firms invest across a broad spectrum of industry verticals, from Therapeutics to Medical Devices, Diagnostics and Life Science tools and platform technologies.
